Thursday, 16 April 2020

Vitamin K2 Market Incredible Possibilities & Growth Analysis and Forecast 2026

The global Vitamin K2 market size is expected to reach USD 290.3 million by 2026 according to a new study by Polaris Market Research. 

The alarming cases of vitamin deficiency in humans are anticipated to be a primary trigger for demand in the global market. A study conducted by the Food & Agriculture Organization of United Nations (FAO) in the year 2018 revealed that vitamin K deficiency bleeding (VKDB) in infants has emerged to be a major concern for infant mortality. Such incidences are anticipated to be the primary demand generators over the forecast period.

The key players in the market include Danisco A/S (DuPont Health and Nutrition), Kappa Bioscience, DSM, BASF, Gnosis SpA, Frutarom, NattoPharma, Seebio Biotech, and Geneferm Biotechnology Co. Ltd. among others. Direct selling proves to be a cost-effective channel for SMEs to gain customer trust.


Osteoporosis is another major ailment which constraints growth of new tissues in the human body. More than 38 million people globally suffered of osteoporosis between 2017-18, as per Osteoporosis Foundation statistics. Hence, compensation of calcium deficiency in the human body is expected to be the main area of vitamin K2 consumption. Multifunctional ingredients ensure extended shelf life of foods, and significantly improve the texture and taste of the end-products, hence these ingredients have become a rage in the pharmaceutical industry. The ageing as well as geriatric population creates a bigger room for manufacturers in terms of product innovation.
  
As far as the production/derivation methods of vitamin K2 are concerned, natural source accounts for a higher share in the market followed by synthetic means. Production method of the ingredient is a crucial concern particularly in the pharmaceutical industry, as manufacturers have to keenly assess the drug testing criteria put forth by governing authorities. The pharmaceuticals and food application segment is expected to consume the highest amount of vitamin K2 as a result of changing lifestyles, health awareness, and rising disposable income of people. Powders and oils are the primary forms through which vitamin K2 would be integrated in foods.

Have Questions? Or make an Inquiry before buying this report Speak to Our Industry Expert: https://www.polarismarketresearch.com/industry-analysis/vitamin-k2-market/speak-to-analyst

As of 2019, North America holds the largest market share followed by Europe and Asia Pacific. A drastic increase in the consumption of functional foods by the citizens of Australia, China, and India are likely to speed up the demand of vitamin K2 in Asia Pacific over the next five years. Middle East and Africa is likely to pose a moderate demand for vitamin K2 because of the already existing health and wellness campaigns deployed by the government.

Mergers & acquisitions (M&A), collaborations, partnerships, capacity expansion plans, heavy amount of research & development, and signing long term distribution contracts with local sales giants are the key strategies adhered by market participants to maintain and strengthen their position in the global landscape.

Direct Purchase Licensed Copy Of Vitamin K2 market : https://www.polarismarketresearch.com/checkouts/6361

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980


on No comments:
Labels: , , , ,

Earphones and Headphones Market Growth Opportunities to Market Players in the Coming Years

According to a new report published by Polaris Market Research the earphones and headphones market is anticipated to reach over USD 16,563 million by 2026. In 2017, earphones dominated the global market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue during the forecast period.

The increasing demand of wireless earphones and headphones drives the growth of this market. Increasing penetration of smartphones coupled with declining prices of mobile devices further accelerates the market growth. In addition, the per capita income of consumers has increased considerably, which has resulted in enhanced lifestyle and higher standards of living. Rise in the number of streaming services such as Spotify, Pandora, and Deezer, enhance the music experience for consumers, thereby supporting the growth of headphones and earphones.


The well-known companies profiled in the report include Sennheiser Electronic GmbH & Co. KG, Sony Corporation, GN Netcom, Audio-Technica Corporation, JVC Corporation, Beats Electronics (Apple, Inc.), Harman International Industries, Inc., Plantronics Pty Ltd., Philips Electronics Ltd., and Bose Corporation among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

There has been an adoption of earphones and headphones across the globe owing to the increase in penetration of smart phones. Growth in sales of smartphones coupled with the increasing need for mobility services has significantly increased the demand for earphones and headphones. The major players in the market have developed advanced wireless headphones and earphones to cater to the growing requirements of consumers and their changing preferences. Additionally, the demand for earphones and headphones has increased in the global market owing to features such as high-definition sound quality, portability, flexibility, and ease of connectivity.
  
A significant growth in demand for wireless earphones and headphones has been registered over the years owing to convenience, portability, and high-definition sound quality. Consumers need convenience and on-the-go services, and opt for wireless earphones and headphones for audio communication and related applications. Wireless earphones and headphones enhance the experience by providing easy and quick transmission, wireless operation, and ease of set up. Hence, the increase in demand for wireless earphones and headphones is expected to drive the growth of the market.

Browse Research Report on Earphones and Headphones Market Analysis : https://www.polarismarketresearch.com/industry-analysis/earphones-and-headphones-market


Improvement in lifestyle due to rise in income level, especially in the developing countries of Asia-Pacific fuels the demand for mobile accessories. Factors such as increase in per capita income and changes in consumer behavior towards adoption of smartphones are expected to accelerate the adoption of earphones and headphones in the coming years.

Asia-Pacific generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The high population in the region coupled with increasing disposable income drives the market growth. The rising penetration of smart phones, and availability of affordable earphones & headphones with advanced features has increased the demand in Asia-Pacific. The increasing application of earphones and headphones in call centers, gaming centers, virtual reality, music and entertainment provide growth opportunities for the market.



The different technologies available in the market include wired and wireless. In 2017, wired earphones and headphones accounted for the highest market share. However, wireless earphones and headphones are expected to grow at a higher CAGR during the forecast period. The increasing demand for wireless earphones and headphones is owing to Bluetooth connectivity, enhanced convenience, increased mobility, and noise cancellation feature.


Contact Us:
Polaris Market Research
Phone: 1–646–568–9980



on No comments:
Labels: , ,

Essential Oil Market 2020-2026 | Growth Factors Analysis, Share and Forecast

According to a new report published by Polaris Market Research the essential oil market is anticipated to reach USD 16,172.2 million by 2026. In 2017, the orange essential oil segment dominated the global market, in terms of revenue. Europe is expected to be the leading contributor to the global market revenue during the forecast period.

A significant increase in disposable income, changing lifestyles, and initiatives by market players to promote healthy lifestyles drive the growth of this market.  Other driving factors include increasing incidences of stress and anxiety, growing inclination towards use of natural and organic products, and increasing awareness regarding physical and mental health. The use of essential oils in various applications such as food and beverages, healthcare, pharmaceutical, cosmetics, and aromatherapy further propel the market growth. Increasing demand in developing nations is expected provide numerous growth opportunities to the market players during the forecast period.


There has been a shift towards e-commerce and consumers are increasingly purchasing essential oils through online platforms. The variety of choices available coupled with ease of purchase offered by online platforms encourages consumers to buy essential oils online, supplementing the growth of the market.
  
Improvement in lifestyle due to rise in income level, especially in the developing countries of Asia-Pacific fuels the demand for essential oils market. Factors such as increase in per capita income and changes in consumer behavior towards physical and mental health are expected to accelerate the adoption of essential oils in the coming years.

Europe generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The high geriatric population in the region coupled with high disposable income drives the market growth. The high demand of essential oils in food & beverages and cosmetic products support the market growth in the region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period owing to increasing disposable incomes in developing countries of this region, rising awareness about benefits of essential oils, and rising demand of essential oils from healthcare sector in this region.


The different types of essential oils in the market include lemon, lime, orange, corn mint, eucalyptus, peppermint, citronella, clove leaf, and others. In 2017, the orange essential oil segment accounted for the highest market share. The increasing demand for orange essential oil is owing to properties such as anti-inflammatory, antidepressant, and antispasmodic. Use of orange essential oil has a calming effect on mind and body, and is used in various cosmetics products. It is also used in various foods and beverages to enhance flavor.

The well-known companies profiled in the report include Dōterra International LLC., Rocky Mountain Oils, LLC, Naturals Together, Robertet SA, Now Health Group, Inc., Biolandes SAS, Falcon Essential Oils, Ungerer Limited, The Lebermuth Company, Flavex Naturextrakte GmbH, Farotti Srl, and E. I. Du Pont De Nemours and Company among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.


Contact Us:
Polaris Market Research
Phone: 1–646–568–9980

on No comments:
Labels: , , ,

Erectile Dysfunction Drugs Market 2020-2025 Future Challenges Outlook

According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Impotence, also known as erectile dysfunction is the condition of sexual dysfunction where, during the sexual intercourse, men cannot maintain the erection. According to World Health Organization statement, for the emotional, physical and wellbeing of the individual, and to the economic and social development of countries and communities, sexual health is a fundamental thing. Erectile dysfunction affects the quality of life for both partners and patients and is connected with relationship difficulties.

Erectile dysfunction is generally an age-related condition but can also be triggered by psychological factors. Cardiovascular diseases such as high blood pressure, clogged arteries etc., diabetes, hormonal insufficiency, chronic kidney disease, multiple sclerosis, injury to the penis, bladder, and pelvis, and neurological issues are the common factor which can cause erectile dysfunction. Moreover, sedentary lifestyle, smoking, excessive alcohol intake, obesity and consumption of drugs such as, antihypertensive drugs, antidepressant, recreational drugs, and psychotropic drugs are some other factors which are significantly contributing towards erectile dysfunction. Exercise, pharmacotherapy, well balanced and maintain lifestyle, penis implants, erection devices, and injections into penis are current treatment available to cure erectile dysfunction. Currently, oral PDE5 (phosphodiesterase type 5 inhibitors) is the first line drug therapy prescribed by physicians for erectile dysfunction.


The availability of oral drugs globally, and rising awareness about erectile dysfunction and sexual diseases is resulting in significant adoption of treatment globally. Moreover, rising number of referrals to secondary care and primary care consultations is expected to propel the growth of erectile dysfunctions drugs market over the forecast period. The increasing elderly population and high rate of chronic diseases such as kidney failure, diabetes, hypertension, hormonal imbalance, and neurological disorders are increasing demand for erectile dysfunction drugs globally.
  
The global erectile dysfunction drugs market is segmented on the basis of drug type, dosage form, end user, and geographically. On the basis of drug type, the global erectile dysfunction market is further segmented into Testosterone, Phosphodiestarse – 5 Inhibitors (PDE5I), Alprostadil, and others. Testosterone is hormone. The lack of testosterone hormone cause impotence or erectile dysfunction, and in such conditions, testosterone hormones are prescribed to the patient to balance the hormone in the body. The Phosphodiestarse – 5 Inhibitors is the drug used to control or block the degenerative action of c-GMP specific phosphodiesterase type 5 (PDE5) on cyclic GMP. The Sildenafil, Vardenafil, Tadalafil, Avanafil, Udenafil are the few examples of Phosphodiestarse – 5 Inhibitors. The Phosphodiestarse – 5 Inhibitors drugs are most commonly prescribed drugs to treat erectile dysfunction and hence accounted major share in global erectile dysfunction drugs market.

Have Questions? make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying

The high effectiveness and efficacy of Phosphodiestarse – 5 Inhibitors are the major factors contributing towards the large share in the global erectile dysfunction market. The introduction of long effective pills such as Levitra (vardenafil) and Cialis (tadalafil) are effective for 36 hours and hence they are also know as weekend pill. Moreover, the increasing research and development and various drugs for erectile dysfunction are in various stages of pipeline. The introduction of such blockbuster drugs in the market over the forecast period is expected to propel the growth of erectile dysfunction market globally.

By dosage form, the global erectile dysfunction drugs market is further sub segmented into topical, oral, injections and others. The oral segment accounted major share in global erectile dysfunction drugs market. The oral drugs are more convenient to handle the dose, and hence it is highly preferable dosage form. The injections segment is expected to grow at high CAGR over the forecast period.


Contact Us:
Polaris Market Research
Phone: 1–646–568–9980



on No comments:
Labels: , , ,

Remote Patient Monitoring Devices Market Trends Global Industry Analysis, Top Manufacturers and Future outlook to 2025

The Global Remote Patient Monitoring Devices Market Size is anticipated to reach over USD 1,882.75 Million by 2025 according to a new research published by Polaris Market Research.

Remote patient monitoring technology comprises devices such as glucose meters, blood pressure monitoring system, and other portable devices that are used by patients at a remote location. Growing usage of smartphones and increasing the expansion of the smartphone applications that are linked to the monitoring devices further helps in transmitting and recording person’s health-related data to the healthcare suppliers or specialists.

The rise in the implementation rate of remote patient monitoring devices, increasing number of geriatric population, and growing incidence of patients suffering from different lifestyle diseases are the major factor boosting the global remote patient monitoring devices market. With the increasing development in wireless technology, such monitoring devices are used to remotely monitor the physical parameters of the person such as heart rate, blood pressure, blood glucose level, and provide proper treatment if necessary. However, the high cost associated with this device, stringent reimbursement guidelines and issues correlated with the government regulations are some of the factors anticipated to hinder the global market growth.


The global Remote Patient Monitoring Devices Market is segmented on the basis of product type, application, end user, and geography.

On the basis of product type, the global Remote Patient Monitoring Devices Market is segmented into Heart Rate Monitors, Heart Monitors, Blood Pressure Monitors, Sleep Apnea Monitors, Breath Monitors, Weight Monitors, Blood Glucose Monitors, Infusion Pumps, and Body Temperature Monitors. On the basis of product type, Heart rate monitor is estimated to dominate the product segment owing to growing global incidences of cardiovascular incidence. The increase in the number of people with cardiac diseases has led to the augmented use of such monitoring devices.
  
On the basis of application, the global Remote Patient Monitoring Devices Market is segmented into Cancer Treatment, Cardiovascular Diseases Treatment, Diabetes Treatment, Sleep Disorder Treatment, Weight Management and Fitness Monitoring. In 2017, cardiovascular disease treatment is estimated to dominate the market growth majorly owing to the increasing incidences of cardiovascular diseases. On the basis of the end user, the global Remote Patient Monitoring Devices Market is segmented into Hospitals, Ambulatory Surgical Centers, and Homecare settings.


On the basis of region, the global Remote Patient Monitoring Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global Remote Patient Monitoring Devices Market. The dominance is majorly attributed to the increasing occurrences of chronic diseases, growing demand for wireless and portable systems, increased level of healthcare spending, growing number of geriatric population, and favorable reimbursement scenarios in this region. However, Asia Pacific is expected to dominate the global Remote Patient Monitoring Devices Market during the forecast. Rising disposable income, high presence of untapped market opportunities primarily in developing economies, advancement in technology, supportive government initiatives are some of the factors expected to significantly boost the Remote Patient Monitoring Devices Market in the Asia Pacific.

Some major key players in global Remote Patient Monitoring Devices Market include Hoffmann-La Roche Ltd., AMD Global Telemedicine, Honeywell International Inc., Omron Healthcare, Smiths Medical, Medtronic among others. The object of the key market players is to deliver better chronic care administration while keeping the cost low. In addition, the companies are concentrating on producing easy-to-use monitoring devices that can aid patients to accomplish conditions including diabetes or heart diseases better by avoiding costly medical processes.


Contact Us:
Polaris Market Research
Phone: 1–646–568–9980



on No comments:
Labels: , , ,

Global Anti-Snoring Devices and Snoring Surgery Market Provides Complete Analysis, Current Trends and Factors Driving Growth


The Global Anti-Snoring Devices and Snoring Surgery Market Size is anticipated to reach over USD 2,461. Million by 2026 according to a new research published by Polaris Market Research.

Snoring is a common sleeping condition caused owing to the airway blockage. Snoring is a symptom or indication of obstructive sleep apnea. The airway block is originated from various causes such as tonsil enlargement, nasal congestion, or improper mouth anatomical structure, which narrow down the passageway of air flow and breathing gets more or less clogged. In addition, usage of sedatives or antidepressant drugs, alcohol consumption, obesity, smoking, and allergies are another factors associated with snoring.

According to the World Health Organizations, currently around 100,000,000 people are suffering snoring problems globally and this problem is highly proportional to the age and hugely found in the age group of 55-60 years. Moreover, according to the American Sleep Association, approximately 50-70 million people have sleep ailments in the U.S. and out of that around 48% are diagnosed to have snoring. The treatment of cumulative affliction of snoring is needed to prevent the risk of obesity, diabetes, mental health issues due to sleep deprivation, gastroesophageal reflux disease, heart diseases, and other complications.


Some major key players in global anti-snoring devices and snoring surgery market includes Apnea Sciences Corporation, Pure Sleep Company, SomnoMed Ltd., Airway Management, Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, Glaxosmithkline Plc, and Meditas Ltd., among others.

The increase in the number of people suffering snoring and larger rising need for budget-friendly, efficacious, and user-friendly, anti-snoring devices are the factors increasing the global anti-snoring devices and snoring surgery market. In addition, even though anti-snoring devices are the prime revenue generator in the global anti-snoring devices and surgery market, it is also anticipated that more people worldwide will undertake surgery to address the snoring disorder.
  
The global anti-snoring devices and snoring surgery market are segmented on the basis of device type, surgical procedure, and geography. On the basis of device type, the global market is categorized into oral applications, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, and Expiratory Positive Airway Pressure. Among these segments, nasal products such as nasal strips and nasal cones are the most popular and widely used as these devices are easy to use and are convenient.


On the basis of surgery type the global anti-snoring devices and snoring surgery market is further categorized into uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. From the surgery type segment, somnoplasty is estimated as the fastest growing segment owing to factors such as minimally invasive, comparatively low surgery cost, less painful, and fewer complications in comparison to the conventional surgical procedures.

North America is estimated to hold the dominant position in the anti-snoring devices and snoring surgery market, due to the growing occurrence of snoring disorders in the region. For instance, according to American Sleep Foundation 2017, approximately 90 million American were estimated to be affected by one or the other respiratory disorder leading to snoring. As an outcome increasing the incidence of snoring is anticipated to increase the demand for its devices and treatment, fueling anti-snoring devices and snoring surgery market. The Asia Pacific is anticipated to dominate the market in the forecast period, owing to growing number of people suffering obesity and respiratory ailments, leading to augment the growth of the anti-snoring devices and snoring surgery market during the forecast period.


Contact Us:
Polaris Market Research
Phone: 1–646–568–9980



on No comments:
Labels: , ,

Pruritus Therapeutics Market Growth Opportunities to Market Players in the Coming Years

The global pruritus therapeutics market is anticipated to reach over USD 17,275.12 Million by 2026, according to a new research published by Polaris Market Research, Pruritus, also known as itch disorder can be triggered by several ailments ranging from dermatological disorders such as mycoses, atopic dermatitis, chickenpox, and contact dermatitis, Pruritus is interrelated with the dermatologic and systemic causes. A typical itching generally forms the diagnosis of a key dermatologic syndrome. Several skin diseases that are related to pruritus include renal pruritus, hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus, pruritus related to malignancy and endocrine pruritus. Renal pruritus can befall in people with chronic renal failure. Increased levels of ions such as calcium, phosphate, and magnesium are found in the skin of pruritic patients.  Severe pruritus leads to scratching that causes secondary skin problems such as eczematization, dryness, infection, excoriation, Contact allergy, and lichenification.

Some major key players in global Pruritus Therapeutics Market include pruritus therapeutics market includes Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical Industries Ltd. among others.


The rising incidence of dermatological disorder influencing the occurrence of pruritus and subsequently, the rising demand for proper diagnostics as well as therapeutics to treat the such medical condition is anticipated to bolster the market growth. The rise in inorganic development strategies is recognized as one of the key factor boosting the growth of the pruritus therapeutic market. In addition, the key players of the pruritus therapeutic market are progressively adapting the growth strategies such as partnerships, regional acquirements, and mergers and acquisitions. Such growth strategies are anticipated to result in technological advancement owing to enhancement in the product portfolio and mutual collaboration in R&D further boosting the market growth.
  
The global pruritus therapeutics market is segmented on the basis of product, disease type, and geography. On the basis of product, the global pruritus therapeutics market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others. In 2017, the corticosteroids are expected to dominate the market by product segment as corticosteroids are widely used as the first line of treatment. On the basis of disease type, the global pruritus therapeutics market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others. In 2017, Allergic contact dermatitis is estimated to dominate the market segment. It is the 3rd most general cause for patients seeking consultation with a dermatology specialist. Allergic contact dermatitis is commonly observed in women.


On the basis of region, the global pruritus therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global pruritus therapeutics market. The dominance is majorly due to The presence of favorable government initiatives and the introduction of new products. Moreover, rising incidence of target disorders and the existence of pruritus inducing climatic disorders in this region are anticipated to boost the market growth during the forecast period. However, Asia Pacific is anticipated to dominate pruritus therapeutics market. Growing incidence of atopic dermatitis and urticarial and presence of unmet healthcare organization needs are the factors attributed to the growth of the market in Asia Pacific.


Contact Us 
Polaris Market Research & Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com




on No comments:
Labels: , , , ,

Optical Coherence Tomography Market Share Worldwide Industry Growth, Size, Statistics, Opportunities and Forecast

The Global Optical Coherence Tomography Market (OCT) Size is anticipated to reach over USD 2,179.75 Million by 2026 according to a new research published by Polaris Market Research. Optical Coherence Tomography (OCT) methods are operative optical diagnostics techniques that cast a 2D as well as the 3D outlook of the retina to help ophthalmological assessments and treatments.  The Optical Coherence Tomography (OCT) Market is basically impelled by the differential need for these methods across several areas of life science and healthcare. The OCT market has been emphasized by the advancement in technologies, furthered by the increasing significance of medical applications in the current scenario.

The range of Optical Coherence Tomography is not limited to ophthalmology and has extended across other medical application such as nephrology, dermatology, and oncology. This factor has amplified the growth scenarios of the Optical Coherence Tomography (OCT) which is anticipated to show intense growth in the forecast period.  The escalation of pathology has also become a devoted contributor to market growth as OCT methods could be employed in the pensive study of micro-level diseases. Furthermore, the non-intrusive nature of OCT has made this technique a prime choice of the medical community for ophthalmic imaging.



The Optical Coherence Tomography (OCT) market has extended its area to the study of ailments such as cardiovascular disruptions, diabetes, esophageal problems, non-melanoma skin cancer, and prostate cancer. This is a significant standpoint for the market as the increasing occurrence of such disorders would create a widespread demand for OCT products. In addition, the emerging economies such as China, Japan, and India have seen operational variations in their healthcare sector which is making developing progress in that regions. This proliferates the demand for OCT devices further propelling the market growth.

The global Optical Coherence Tomography (OCT) Market is segmented on the basis of technology, type, application, and geography. On the basis of technology, the global Optical Coherence Tomography (OCT) Market is segmented into Time Domain Optical Coherence Tomography (TDOCT), Frequency Domain Optical Coherence Tomography (FD-OCT), and Spatially Encoded Frequency Domain Optical Coherence Tomography. The Spatially Encoded Frequency Domain Optical Coherence Tomography is further categorized into Spectral Domain Optical Coherence Tomography (SDOCT) and Fourier Domain Optical Coherence Tomography (FDOCT).

On the basis of type, the global Optical Coherence Tomography (OCT) Market is segmented into Catheter-based OCT devices, Doppler OCT devices, Handheld OCT devices, and Tabletop OCT devices. In 2017, the handheld type segment was estimated to dominate the market. The dominance is attributed to the higher product penetration in developed regions such as U.S., U.K., Germany, and Brazil.


On the basis of application, the global Optical Coherence Tomography (OCT) Market is segmented into Ophthalmology, Cardiovascular, Oncology, Dermatology, and others. In 2017, ophthalmology segment is estimated to dominate the market growth. Introduction of higher performing devices with accurateness, improved performance, and easiness of use coupled with the supplementing occurrences of choroidal and retinal disorders is the vigorous impact rendering factor enhancing the market growth.

Some major key players in global Optical Coherence Tomography (OCT) Market include Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Topcon Medical Systems Inc. and Thorlabs Inc. among others.


Contact Us 
Polaris Market Research & Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
on No comments:
Labels: , ,
Subscribe to: Comments (Atom)